SMTL ID : 1inh.1

INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

homo-tetramer

Ligands

8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 7 residues within 4Å: Chain A: E.2, N.5, S.7, K.8, Y.203 Ligands: NAG-NAG.4, NAG-NAG.4 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 7 residues within 4Å: Chain A: I.152, N.153, Y.203, P.204, M.226, E.227 Ligands: NAG-NAG.1 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 7 residues within 4Å: Chain B: E.2, N.5, S.7, K.8, Y.203 Ligands: NAG-NAG.8, NAG-NAG.8 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 7 residues within 4Å: Chain B: I.152, N.153, Y.203, P.204, M.226, E.227 Ligands: NAG-NAG.5 No protein-ligand interaction detected (PLIP) NAG-NAG.13: 7 residues within 4Å: Chain C: E.2, N.5, S.7, K.8, Y.203 Ligands: NAG-NAG.16, NAG-NAG.16 No protein-ligand interaction detected (PLIP) NAG-NAG.16: 7 residues within 4Å: Chain C: I.152, N.153, Y.203, P.204, M.226, E.227 Ligands: NAG-NAG.13 No protein-ligand interaction detected (PLIP) NAG-NAG.17: 7 residues within 4Å: Chain D: E.2, N.5, S.7, K.8, Y.203 Ligands: NAG-NAG.20, NAG-NAG.20 No protein-ligand interaction detected (PLIP) NAG-NAG.20: 7 residues within 4Å: Chain D: I.152, N.153, Y.203, P.204, M.226, E.227 Ligands: NAG-NAG.17 No protein-ligand interaction detected (PLIP)

2 x NAG- NAG- BMA- FUL: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-FUL.2: 7 residues within 4Å: Chain A: N.65, D.66, H.69, W.356, I.388 Chain B: N.382, F.385 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.65, A:D.66 NAG-NAG-BMA-FUL.14: 7 residues within 4Å: Chain C: N.65, D.66, H.69, W.356, I.388 Chain D: N.382, F.385 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:N.65, C:D.66

2 x NAG- NAG- BMA- MAN- BMA- MAN: beta-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-BMA-MAN.3: 20 residues within 4Å: Chain A: N.119 Chain B: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.312, B:N.312, B:R.313, B:I.311, B:R.313, B:R.313, B:T.374 NAG-NAG-BMA-MAN-BMA-MAN.15: 20 residues within 4Å: Chain C: N.119 Chain D: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375 1 PLIP interactions: 1 interactions with chain D Hydrogen bonds: D:N.312, D:N.312, D:R.313, D:I.311, D:R.313, D:R.313, D:T.374

2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-FUC.6: 7 residues within 4Å: Chain B: N.65, D.66, H.69, W.356, I.388 Chain C: N.382, F.385 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.65, B:D.66 NAG-NAG-BMA-FUC.18: 7 residues within 4Å: Chain A: N.382, F.385 Chain D: N.65, D.66, H.69, W.356, I.388 2 PLIP interactions: 2 interactions with chain D Hydrogen bonds: D:N.65, D:D.66

2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN.7: 20 residues within 4Å: Chain B: N.119 Chain C: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.312, C:N.312, C:R.313, C:Q.310, C:Q.310, C:R.313, C:R.313, C:R.313, C:T.374 NAG-NAG-BMA-MAN-MAN-MAN.19: 20 residues within 4Å: Chain A: T.14, G.15, F.16, L.240, W.280, T.295, F.296, K.297, S.309, Q.310, I.311, N.312, R.313, Q.314, V.315, Y.372, G.373, T.374, G.375 Chain D: N.119 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.312, A:N.312, A:R.313, A:Q.310, A:Q.310, A:R.313, A:R.313, A:R.313, A:T.374

4 x CA: CALCIUM ION(Non-covalent)

CA.9: 6 residues within 4Å: Chain A: D.212, G.216, D.243, G.264, T.265, Q.266 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:D.212, A:G.216, A:G.264, A:Q.266 CA.11: 6 residues within 4Å: Chain B: D.212, G.216, D.243, G.264, T.265, Q.266 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:D.212, B:G.216, B:G.264, B:Q.266 CA.21: 6 residues within 4Å: Chain C: D.212, G.216, D.243, G.264, T.265, Q.266 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:D.212, C:G.216, C:G.264, C:Q.266 CA.23: 6 residues within 4Å: Chain D: D.212, G.216, D.243, G.264, T.265, Q.266 4 PLIP interactions: 4 interactions with chain D Metal complexes: D:D.212, D:G.216, D:G.264, D:Q.266

4 x ST6: 4-(ACETYLAMINO)-3-[(AMINOACETYL)AMINO]BENZOIC ACID(Non-covalent)

ST6.10: 12 residues within 4Å: Chain A: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:D.70, A:W.97 Hydrogen bonds: A:D.70, A:R.71, A:E.195, A:R.211, A:Y.325 Salt bridges: A:R.37, A:R.290 ST6.12: 12 residues within 4Å: Chain B: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:D.70, B:W.97 Hydrogen bonds: B:D.70, B:R.71, B:E.195, B:R.211, B:Y.325 Salt bridges: B:R.37, B:R.290 ST6.22: 12 residues within 4Å: Chain C: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:D.70, C:W.97 Hydrogen bonds: C:D.70, C:D.70, C:R.71, C:E.195, C:R.211, C:Y.325 Salt bridges: C:R.37, C:R.290 ST6.24: 12 residues within 4Å: Chain D: R.37, E.38, D.70, R.71, W.97, R.143, E.146, E.195, E.196, R.211, R.290, Y.325 10 PLIP interactions: 10 interactions with chain D Hydrophobic interactions: D:D.70, D:W.97 Hydrogen bonds: D:D.70, D:D.70, D:R.71, D:E.195, D:R.211, D:Y.325 Salt bridges: D:R.37, D:R.290

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Singh, S. et al., Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. J.Med.Chem. (1995)

Release Date

1996-08-17

Peptides

INFLUENZA A SUBTYPE N2 NEURAMINIDASE: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

INFLUENZA A SUBTYPE N2 NEURAMINIDASE

Related Entries With Identical Sequence